Results
1451
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
1,451 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
A178320 | ₩29,900.00 | -5.1% | 67.8% | ₩1.7t | ₩39,333.33 | PE154.8x | E58.7% | 0% | Tech | ||
4480 | JP¥4,375.00 | 4.9% | -15.0% | JP¥141.9b | JP¥5,800.00 | PE53.1x | E28.7% | n/a | Healthcare | ||
CTT | AU$1.35 | -5.3% | -56.3% | AU$551.8m | AU$3.12 | PE26.6x | E26.7% | n/a | Retail | ||
YGG | ฿1.22 | -14.1% | -84.4% | ฿734.4m | ฿10.75 | PE10.7x | E33.5% | 22.0% | Media | ||
PLT | AU$0.71 | -4.0% | 78.8% | AU$125.4m | AU$1.30 | PS1.7x | E106.4% | n/a | Diversified Financials | ||
517522 | ₹581.70 | -4.2% | -24.5% | ₹29.5b | ₹772.00 | PE41.1x | E33.5% | 0.3% | Materials | ||
GIG | NOK 30.20 | 0.7% | 9.8% | NOK 4.1b | NOK 45.03 | PE18.6x | E37.4% | n/a | Consumer Services | ||
CALTX | SEK 206.40 | 0.3% | 138.3% | SEK 11.2b | SEK 221.25 | PS8.5x | E52.9% | n/a | Pharmaceuticals & Biotech | ||
505283 | ₹1,348.75 | 1.8% | 109.7% | ₹87.4b | ₹1,705.00 | PE61.4x | E30.8% | 0.5% | Capital Goods | ||
CRDO | US$29.50 | -4.4% | 80.8% | US$4.9b | US$30.33 | PS25.3x | E60.9% | n/a | Semiconductors | ||
KEBNI B | SEK 1.46 | -4.1% | 1.0% | SEK 395.3m | SEK 2.20 | PS4.3x | E90.4% | n/a | Tech | ||
VOW | NOK 7.68 | 14.3% | -49.3% | NOK 874.3m | NOK 11.00 | PB2.2x | E97.7% | 0% | Commercial Services | ||
CUV | AU$15.53 | -0.8% | -14.0% | AU$777.7m | AU$30.33 | PE25.8x | E26.8% | 0.3% | Pharmaceuticals & Biotech | ||
EH | US$12.01 | -23.9% | -29.8% | US$760.1m | US$24.98 | PS35.2x | E74.3% | n/a | Capital Goods | ||
A179900 | ₩31,600.00 | 1.3% | 45.6% | ₩500.0b | ₩60,000.00 | PS24.9x | E122.7% | 0% | Tech | ||
A441270 | ₩9,010.00 | -2.2% | 6.5% | ₩333.1b | ₩11,500.00 | PE21.4x | E36.4% | n/a | Tech | ||
688408 | CN¥66.53 | 5.5% | 39.1% | CN¥13.3b | CN¥66.22 | PE29x | E25.4% | 0.9% | Capital Goods | ||
A204620 | ₩3,985.00 | -1.8% | 18.4% | ₩226.3b | ₩7,100.00 | PS2.1x | E72.4% | n/a | Commercial Services | ||
ADOC | €6.23 | 14.5% | 52.3% | €93.7m | €6.30 | PS15.5x | E63.0% | n/a | Pharmaceuticals & Biotech | ||
300181 | CN¥14.46 | -3.7% | 27.4% | CN¥10.1b | n/a | PE23.7x | E22.3% | 3.1% | Pharmaceuticals & Biotech | ||
A067310 | ₩20,400.00 | 5.0% | -0.2% | ₩967.5b | ₩31,666.67 | PB3.3x | E99.6% | 0.2% | Semiconductors | ||
ACI | ₹684.30 | -3.9% | 29.1% | ₹84.4b | ₹757.20 | PE26.5x | E28.9% | 0.4% | Materials | ||
6782 | NT$266.00 | -7.6% | 40.7% | NT$16.8b | NT$323.60 | PE38.7x | E33.5% | 0.9% | Healthcare | ||
2707 | CN¥6.97 | 0.7% | -9.2% | CN¥6.8b | CN¥5.80 | PE70x | E33.1% | 0% | Consumer Services |